Patient Capital Management LLC Sells 35,310 Shares of Citigroup Inc. $C

Patient Capital Management LLC lessened its holdings in shares of Citigroup Inc. (NYSE:CFree Report) by 2.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,310,407 shares of the company’s stock after selling 35,310 shares during the period. Citigroup accounts for approximately 5.3% of Patient Capital Management LLC’s investment portfolio, making the stock its 2nd biggest holding. Patient Capital Management LLC’s holdings in Citigroup were worth $133,006,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in C. FMB Wealth Management raised its stake in Citigroup by 4.1% during the 3rd quarter. FMB Wealth Management now owns 2,618 shares of the company’s stock worth $266,000 after acquiring an additional 103 shares in the last quarter. Tritonpoint Wealth LLC boosted its position in shares of Citigroup by 2.1% in the 3rd quarter. Tritonpoint Wealth LLC now owns 4,989 shares of the company’s stock valued at $506,000 after purchasing an additional 104 shares during the period. Onyx Bridge Wealth Group LLC grew its stake in Citigroup by 3.6% during the 2nd quarter. Onyx Bridge Wealth Group LLC now owns 3,117 shares of the company’s stock worth $265,000 after buying an additional 109 shares during the last quarter. Highline Wealth Partners LLC lifted its stake in Citigroup by 35.3% in the third quarter. Highline Wealth Partners LLC now owns 418 shares of the company’s stock valued at $42,000 after buying an additional 109 shares during the last quarter. Finally, Fullcircle Wealth LLC boosted its holdings in shares of Citigroup by 0.9% in the second quarter. Fullcircle Wealth LLC now owns 13,097 shares of the company’s stock valued at $1,206,000 after acquiring an additional 111 shares during the period. Institutional investors and hedge funds own 71.72% of the company’s stock.

Citigroup Stock Down 4.3%

Shares of NYSE C opened at $112.96 on Wednesday. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.00 and a quick ratio of 0.99. The firm’s 50-day moving average is $111.25 and its two-hundred day moving average is $101.65. Citigroup Inc. has a 12-month low of $55.51 and a 12-month high of $124.17. The company has a market capitalization of $202.11 billion, a PE ratio of 16.21, a price-to-earnings-growth ratio of 0.58 and a beta of 1.18.

Citigroup (NYSE:CGet Free Report) last announced its earnings results on Wednesday, January 14th. The company reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.65 by $0.16. Citigroup had a return on equity of 8.28% and a net margin of 8.50%.The firm had revenue of $19.87 billion for the quarter, compared to analysts’ expectations of $20.99 billion. During the same quarter in the prior year, the firm earned $1.34 EPS. Citigroup’s quarterly revenue was up 2.1% on a year-over-year basis. Equities analysts anticipate that Citigroup Inc. will post 7.53 EPS for the current fiscal year.

Citigroup Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Monday, February 2nd will be paid a $0.60 dividend. The ex-dividend date of this dividend is Monday, February 2nd. This represents a $2.40 annualized dividend and a yield of 2.1%. Citigroup’s payout ratio is presently 34.43%.

Key Stories Impacting Citigroup

Here are the key news stories impacting Citigroup this week:

Analysts Set New Price Targets

Several brokerages have issued reports on C. TD Cowen raised their price objective on shares of Citigroup from $105.00 to $110.00 and gave the stock a “hold” rating in a research report on Wednesday, October 15th. Cowen restated a “hold” rating on shares of Citigroup in a research report on Wednesday, January 7th. Oppenheimer increased their price objective on Citigroup from $141.00 to $144.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Weiss Ratings reissued a “buy (b)” rating on shares of Citigroup in a report on Wednesday, October 8th. Finally, Bank of America upped their price target on Citigroup from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, October 15th. Fourteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, Citigroup presently has a consensus rating of “Moderate Buy” and an average target price of $124.65.

Read Our Latest Report on C

About Citigroup

(Free Report)

Citigroup Inc is a global financial services company headquartered in New York City with roots tracing back to the City Bank of New York, founded in 1812. The modern Citigroup was created through the 1998 merger of Citicorp and Travelers Group and has since operated as a diversified bank holding company that provides a broad range of banking and financial products and services to consumers, corporations, governments and institutions worldwide.

Citi’s principal businesses include retail and commercial banking, credit card and consumer lending products, wealth management and private banking, and a full suite of institutional services.

See Also

Want to see what other hedge funds are holding C? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Citigroup Inc. (NYSE:CFree Report).

Institutional Ownership by Quarter for Citigroup (NYSE:C)

Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.